These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36006892)

  • 41. Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.
    Chaari A; Mohamed AS; Abdelhakim K; Kauts V; Casey WF
    Int J Clin Pharm; 2017 Oct; 39(5):998-1003. PubMed ID: 28780739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is the anticonvulsant activity of levetiracetam dose-dependent?
    Lamouret V; Kurth C; Intravooth T; Steinhoff BJ
    Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
    Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B
    Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of tolerance to levetiracetam in rats with chronic epilepsy.
    van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA
    Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
    Martinez Ferri M; Peña Mayor P; Perez López-Fraile I; Escartin Siquier A; Martin Moro M; Forcadas Berdusan M;
    Neurologia (Engl Ed); 2018 Mar; 33(2):78-84. PubMed ID: 27452623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The risk of hypotension and seizures in patients receiving prophylactic anti-epileptic drugs for supratentorial craniotomy.
    Höhne J; Schebesch KM; Ott C; Brawanski A; Lange M
    J Neurosurg Sci; 2018 Aug; 62(4):418-422. PubMed ID: 27854111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].
    Auriel E; Chistik V; Blatt I; Margolin N; Neufeld M
    Harefuah; 2007 Apr; 146(4):269-71, 318. PubMed ID: 17476932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury.
    Pieracci FM; Moore EE; Beauchamp K; Tebockhorst S; Barnett CC; Bensard DD; Burlew CC; Biffl WL; Stoval RT; Johnson JL
    J Trauma Acute Care Surg; 2012 Jan; 72(1):276-81. PubMed ID: 22310136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin B6 decreases the risk of levetiracetam discontinuation in children with epilepsy: A retrospective study.
    Lob K; Bassell-Hawkins J; Patil R; Nie D; Bartolini L
    Epilepsy Behav; 2022 Sep; 134():108839. PubMed ID: 35839645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
    Ben-Menachem E; Falter U
    Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of levetiracetam for early post-traumatic seizure prophylaxis: A level II trauma center experience.
    Amin TA; Nerenberg SF; Elsawy OA; Wang A; Johnston JP
    Surgeon; 2023 Apr; 21(2):e78-e82. PubMed ID: 35660071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal Dosing of Levetiracetam for Seizure Prophylaxis in Critically Ill Patients: A Prospective Observational Study.
    Valdes E; Fang T; Boffa M; Frontera JA
    Crit Care Med; 2024 Jan; 52(1):e1-e10. PubMed ID: 37734033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of endothelin B receptor improves the efficacy of levetiracetam in chronic epileptic rats.
    Ko AR; Kang TC
    Seizure; 2015 Sep; 31():133-40. PubMed ID: 26362390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
    Bansal S; Blalock D; Kebede T; Dean NP; Carpenter JL
    J Neurosurg Pediatr; 2014 Feb; 13(2):209-15. PubMed ID: 24286154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levetiracetam versus phenytoin in management of status epilepticus.
    Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P
    J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levetiracetam as an antiepileptic, neuroprotective, and hyperalgesic drug.
    Cortes-Altamirano JL; Olmos-Hernández A; Bonilla-Jaime H; Bandala C; González-Maciel A; Alfaro-Rodríguez A
    Neurol India; 2016; 64(6):1266-1275. PubMed ID: 27841198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil.
    Wu PP; Cao BR; Tian FY; Gao ZB
    Neurosci Bull; 2024 May; 40(5):594-608. PubMed ID: 37897555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.